Kenya and Pfizer are exploring an expanded health and investment partnership following a review of their existing Memorandum of Understanding (MoU). The renewed agreement aims to enhance access to medicines and vaccines while fostering broader collaboration.

• The partnership will support not-for-profit access to Pfizer medicines and vaccines, alongside supply-chain strengthening and workforce development.
• Key figures involved include Principal Secretary for Medical Services Dr. Ouma Oluga and Pfizer Biopharmaceuticals Group Vice President Ali Besri.
• Discussions also focused on evolving the collaboration to include clinical trials, technology transfer, local manufacturing, and establishing Kenya as an East African logistics hub, aligning with national manufacturing strategies.